KALA BIO, Inc.
KALA
$3.75
$0.030.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.24% | -2.83% | 8.01% | 18.32% | 32.83% |
| Total Depreciation and Amortization | -1.43% | -20.25% | -20.78% | -14.29% | -12.50% |
| Total Amortization of Deferred Charges | -4.17% | 4.21% | 3.96% | -5.17% | 5.76% |
| Total Other Non-Cash Items | -20.05% | 172.16% | 21.19% | -10.84% | 31.47% |
| Change in Net Operating Assets | 147.18% | -85.54% | -370.18% | -244.70% | 34.80% |
| Cash from Operations | 40.25% | -60.06% | -21.33% | -11.98% | 43.97% |
| Capital Expenditure | -885.71% | 67.97% | 83.18% | 87.96% | 68.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -885.71% | -100.93% | 99.64% | 87.96% | -113.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 1,947.89% | -- | 387.15% | -99.86% | -98.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 94.17% | -- |
| Cash from Financing | 162.17% | -550.00% | 387.15% | 195.31% | -92.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.29% | -173.38% | 139.29% | 65.14% | -128.55% |